1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Another win for big pharma by their freinds in senate

  1. Heretic.Ape.
    Senate blocks bid to allow prescription drug imports
    By Associated Press
    Monday, May 7, 2007 - Updated: 05:10 PM EST

    WASHINGTON - The Senate effectively killed a bid to allow consumers to buy their prescription medicines abroad Monday, requiring U.S. officials to certify the safety and effectiveness of such drugs.
    The certification amendment, passed on a 49-40 vote, would require health officials to do something they have long said they cannot.
    Because of that, the vote undercut a second measure that would permit prescription drug imports from Food and Drug Administration-approved sources in Canada, Australia, Europe, Japan and New Zealand.
    The Bush administration opposes allowing imports of prescription drugs, and the White House had threatened a veto.
    Sen. Bernie Sanders, I-Vt., called the certification amendment, introduced by Sen. Thad Cochran, R-Miss., a "poison pill" for the drug-imports legislation. Sen. Byron Dorgan, D-N.D., acknowledged it voided his bid to allow the purchase of drugs abroad.
    Overseas, drugs can cost two-thirds less than they do in the United States, where prices for brand-name drugs are among the highest in the world. In many industrialized countries, prices are lower because they are either controlled or partially controlled by government regulation.
    Allowing imports from those countries would drive down U.S. brand-name drug prices, Dorgan has said.
    Both the Cochran and Dorgan measures were amendments to broader FDA legislation.
    The idea of allowing prescription drug imports enjoys broad popular support. However, lower prices overseas would not automatically translate into large savings for domestic consumers, according to a 2004 study by the Congressional Budget Office.
    The study found that allowing drug imports from a broad set of countries would cut U.S. drug spending by $40 billion over 10 years, about a 1 percent savings.
    The pharmaceutical industry vehemently opposes allowing drug imports, arguing that they could leave the nation vulnerable to dangerous counterfeits.
    Similar drug-import legislation is pending in the House.


To make a comment simply sign up and become a member!